Lama Pemberian Obat Anti Tuberkulosa dan Kadar Zinc Serum Pasien Paru Anak (Studi Kasus di Kabupaten Bogor)

<p class="Pa18"><strong>LAMA PEMBERIAN OBAT ANTI TUBERKULOSA </strong></p> <p class="Pa18"><strong>DAN KADAR ZINC SERUM PASIEN PARU ANAK</strong></p> <p class="Pa18"><strong>(STUDI KASUS DI KABUPATEN BOGOR)<...

Full description

Bibliographic Details
Main Authors: Made Dewi Susilawati, Amalia Safitri, Yurista Permanasari
Format: Article
Language:English
Published: Balai Penelitian dan Pengembangan Kesehatan Magelang 2016-01-01
Series:Media Gizi Mikro Indonesia
Online Access:http://ejournal.litbang.kemkes.go.id/index.php/mgmi/article/view/4518
id doaj-801d0bb7cbf74cd481124783ddd802da
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Made Dewi Susilawati
Amalia Safitri
Yurista Permanasari
spellingShingle Made Dewi Susilawati
Amalia Safitri
Yurista Permanasari
Lama Pemberian Obat Anti Tuberkulosa dan Kadar Zinc Serum Pasien Paru Anak (Studi Kasus di Kabupaten Bogor)
Media Gizi Mikro Indonesia
author_facet Made Dewi Susilawati
Amalia Safitri
Yurista Permanasari
author_sort Made Dewi Susilawati
title Lama Pemberian Obat Anti Tuberkulosa dan Kadar Zinc Serum Pasien Paru Anak (Studi Kasus di Kabupaten Bogor)
title_short Lama Pemberian Obat Anti Tuberkulosa dan Kadar Zinc Serum Pasien Paru Anak (Studi Kasus di Kabupaten Bogor)
title_full Lama Pemberian Obat Anti Tuberkulosa dan Kadar Zinc Serum Pasien Paru Anak (Studi Kasus di Kabupaten Bogor)
title_fullStr Lama Pemberian Obat Anti Tuberkulosa dan Kadar Zinc Serum Pasien Paru Anak (Studi Kasus di Kabupaten Bogor)
title_full_unstemmed Lama Pemberian Obat Anti Tuberkulosa dan Kadar Zinc Serum Pasien Paru Anak (Studi Kasus di Kabupaten Bogor)
title_sort lama pemberian obat anti tuberkulosa dan kadar zinc serum pasien paru anak (studi kasus di kabupaten bogor)
publisher Balai Penelitian dan Pengembangan Kesehatan Magelang
series Media Gizi Mikro Indonesia
issn 2086-5198
2354-8746
publishDate 2016-01-01
description <p class="Pa18"><strong>LAMA PEMBERIAN OBAT ANTI TUBERKULOSA </strong></p> <p class="Pa18"><strong>DAN KADAR ZINC SERUM PASIEN PARU ANAK</strong></p> <p class="Pa18"><strong>(STUDI KASUS DI KABUPATEN BOGOR)</strong></p> <p class="Default"> </p> <p class="Pa18"><strong>Anti Tuberculosis Drugs Treatment Duration </strong></p> <p class="Pa18"><strong>and Serum Zinc Level of Child Patients </strong></p> <p class="Pa18"><strong>(A Case Study in Bogor District)</strong></p> <p class="Pa42"><strong><em> </em></strong></p> <p class="Pa42"><strong><em>ABSTRACT</em></strong></p> <p class="Pa42"><strong><em>Background. </em></strong><em>Zinc is a potent mediator to body endurance against infection by affecting the function of the cellular immune system which act as the main response in tuberculosa infection. Low level of zinc in the blood, called hipozinsemia, is more often found in child tuberculosis (TB) patients who have not taken anti tuberculoses drugs than those who have received drug therapy. Several previous studies show that there were no different levels of zinc between intensive phase and follow-up phase of therapies, however others indicated contrary results. <strong>Objective. </strong>The purpose of study is to determine whether there is any differences of serum zinc levels in the intensive phase and follow-up phase of anti-tuberculosis drug as well as to assess the relationship between treatment duration and serum zinc levels. <strong>Method. </strong>A cross-sectional study design was used with research subjects were children aged 6-59 months who were taken anti-tuberculosis drugs in Bogor District, in 2013. Data analysis used was independent t test and correlation test. <strong>Results. </strong>There was significant mean difference of serum zinc levels between subject who took anti-tuberculosis drugs in the intensive phase compare to those in the follow-up phase (p=0.015).There was a significant positive correlation between the duration of treatment and the serum zinc levels after controlling nutritional status (r=</em>0.363 p=0.003). <strong><em>Conclusion. </em></strong><em>Serum zinc levels will increase linearly with tuberculosis drugs treatment duration. A further research is needed to determine whether there is any benefit of zinc supplementation in the intensive phase.</em></p> <p class="Pa42"><strong><em>Keywords: </em></strong><em>anti tuberculosis drug, pulmonary tuberculosis, zinc.</em></p> <p class="Default"> </p> <p class="Pa42"><strong>ABSTRAK</strong></p> <p class="Pa42"><strong>Latar Belakang. </strong>Zinc merupakan mediator yang memiliki kemampuan terkait daya tahan tubuh untuk melawan infeksi dengan mempengaruhi fungsi sistem imun sel yang merupakan respons imun utama pada infeksi tuberkulosa (TB). Kadar zinc dalam darah yang rendah atau hipozinsemia lebih banyak ditemukan pada pasien TB paru anak yang belum mendapat obat anti tuberkulosa (OAT) dibandingkan pasien yang telah mendapatkan OAT. Beberapa penelitian sebelumnya ada yang menunjukkan kadar zinc tidak berbeda antara pemberian OAT fase intensif dengan fase lanjutan, namun ada juga yang menunjukkan hasil sebaliknya. <strong>Tujuan</strong>. Penelitian ini bertujuan untuk mengetahui ada tidaknya perbedaan kadar zinc serum saat pemberian OAT pada fase intensif dan fase lanjutan serta menilai keeratan hubungan antara lama pengobatan dengan kadar zinc serum. <strong>Metode</strong>. Desain penelitian potong lintang yang merupakan studi kasus TB paru pada anak umur 6-59 bulan di wilayah kerja puskesmas Kabupaten Bogor tahun 2013. Analisis data menggunakan uji <em>t test </em>tidak berpasangan dan uji korelasi. <strong>Hasil.</strong>Ada perbedaan rerata kadar zinc antara anak yang mendapatkan pengobatan di fase intensif dibandingkan yang mendapatkan pengobatan di fase lanjutan (p=0.015). Ada korelasi positif dan bermakna antara lama pengobatan dengan kadar zinc serum setelah faktor status gizi dikontrol (r=0.363 p=0.003) <strong>Kesimpulan.</strong> Kadar zinc serum akan meningkat seiring dengan jangka waktu terapi OAT yang diberikan. Perlu adanya penelitian lebih lanjut yang bertujuan untuk mengetahui ada tidaknya manfaat pemberian suplemen mikronutrien zinc pada fase intensif.</p> <p class="Default"><strong>Kata kunci: </strong>OAT, tuberkulosa paru, zinc.</p>
url http://ejournal.litbang.kemkes.go.id/index.php/mgmi/article/view/4518
work_keys_str_mv AT madedewisusilawati lamapemberianobatantituberkulosadankadarzincserumpasienparuanakstudikasusdikabupatenbogor
AT amaliasafitri lamapemberianobatantituberkulosadankadarzincserumpasienparuanakstudikasusdikabupatenbogor
AT yuristapermanasari lamapemberianobatantituberkulosadankadarzincserumpasienparuanakstudikasusdikabupatenbogor
_version_ 1725145413576556544
spelling doaj-801d0bb7cbf74cd481124783ddd802da2020-11-25T01:17:51ZengBalai Penelitian dan Pengembangan Kesehatan MagelangMedia Gizi Mikro Indonesia2086-51982354-87462016-01-016211112210.22435/mgmi.v6i2.4518.111-1224075Lama Pemberian Obat Anti Tuberkulosa dan Kadar Zinc Serum Pasien Paru Anak (Studi Kasus di Kabupaten Bogor)Made Dewi Susilawati0Amalia Safitri1Yurista Permanasari2Pusat Teknologi Terapan Kesehatan dan Epidemiologi KlinikPusat Teknologi Terapan Kesehatan dan Epidemiologi KlinikPusat Teknologi Terapan Kesehatan dan Epidemiologi Klinik<p class="Pa18"><strong>LAMA PEMBERIAN OBAT ANTI TUBERKULOSA </strong></p> <p class="Pa18"><strong>DAN KADAR ZINC SERUM PASIEN PARU ANAK</strong></p> <p class="Pa18"><strong>(STUDI KASUS DI KABUPATEN BOGOR)</strong></p> <p class="Default"> </p> <p class="Pa18"><strong>Anti Tuberculosis Drugs Treatment Duration </strong></p> <p class="Pa18"><strong>and Serum Zinc Level of Child Patients </strong></p> <p class="Pa18"><strong>(A Case Study in Bogor District)</strong></p> <p class="Pa42"><strong><em> </em></strong></p> <p class="Pa42"><strong><em>ABSTRACT</em></strong></p> <p class="Pa42"><strong><em>Background. </em></strong><em>Zinc is a potent mediator to body endurance against infection by affecting the function of the cellular immune system which act as the main response in tuberculosa infection. Low level of zinc in the blood, called hipozinsemia, is more often found in child tuberculosis (TB) patients who have not taken anti tuberculoses drugs than those who have received drug therapy. Several previous studies show that there were no different levels of zinc between intensive phase and follow-up phase of therapies, however others indicated contrary results. <strong>Objective. </strong>The purpose of study is to determine whether there is any differences of serum zinc levels in the intensive phase and follow-up phase of anti-tuberculosis drug as well as to assess the relationship between treatment duration and serum zinc levels. <strong>Method. </strong>A cross-sectional study design was used with research subjects were children aged 6-59 months who were taken anti-tuberculosis drugs in Bogor District, in 2013. Data analysis used was independent t test and correlation test. <strong>Results. </strong>There was significant mean difference of serum zinc levels between subject who took anti-tuberculosis drugs in the intensive phase compare to those in the follow-up phase (p=0.015).There was a significant positive correlation between the duration of treatment and the serum zinc levels after controlling nutritional status (r=</em>0.363 p=0.003). <strong><em>Conclusion. </em></strong><em>Serum zinc levels will increase linearly with tuberculosis drugs treatment duration. A further research is needed to determine whether there is any benefit of zinc supplementation in the intensive phase.</em></p> <p class="Pa42"><strong><em>Keywords: </em></strong><em>anti tuberculosis drug, pulmonary tuberculosis, zinc.</em></p> <p class="Default"> </p> <p class="Pa42"><strong>ABSTRAK</strong></p> <p class="Pa42"><strong>Latar Belakang. </strong>Zinc merupakan mediator yang memiliki kemampuan terkait daya tahan tubuh untuk melawan infeksi dengan mempengaruhi fungsi sistem imun sel yang merupakan respons imun utama pada infeksi tuberkulosa (TB). Kadar zinc dalam darah yang rendah atau hipozinsemia lebih banyak ditemukan pada pasien TB paru anak yang belum mendapat obat anti tuberkulosa (OAT) dibandingkan pasien yang telah mendapatkan OAT. Beberapa penelitian sebelumnya ada yang menunjukkan kadar zinc tidak berbeda antara pemberian OAT fase intensif dengan fase lanjutan, namun ada juga yang menunjukkan hasil sebaliknya. <strong>Tujuan</strong>. Penelitian ini bertujuan untuk mengetahui ada tidaknya perbedaan kadar zinc serum saat pemberian OAT pada fase intensif dan fase lanjutan serta menilai keeratan hubungan antara lama pengobatan dengan kadar zinc serum. <strong>Metode</strong>. Desain penelitian potong lintang yang merupakan studi kasus TB paru pada anak umur 6-59 bulan di wilayah kerja puskesmas Kabupaten Bogor tahun 2013. Analisis data menggunakan uji <em>t test </em>tidak berpasangan dan uji korelasi. <strong>Hasil.</strong>Ada perbedaan rerata kadar zinc antara anak yang mendapatkan pengobatan di fase intensif dibandingkan yang mendapatkan pengobatan di fase lanjutan (p=0.015). Ada korelasi positif dan bermakna antara lama pengobatan dengan kadar zinc serum setelah faktor status gizi dikontrol (r=0.363 p=0.003) <strong>Kesimpulan.</strong> Kadar zinc serum akan meningkat seiring dengan jangka waktu terapi OAT yang diberikan. Perlu adanya penelitian lebih lanjut yang bertujuan untuk mengetahui ada tidaknya manfaat pemberian suplemen mikronutrien zinc pada fase intensif.</p> <p class="Default"><strong>Kata kunci: </strong>OAT, tuberkulosa paru, zinc.</p>http://ejournal.litbang.kemkes.go.id/index.php/mgmi/article/view/4518